Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $32.22
Latest analyst grade actions
267 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 54.48 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 69.88 | Oscillator | Neutral |
| Williams %R (14) | -11.63 | Oscillator | Sell |
| MACD (12, 26, 9) | -0.25 (Hist 0.18) | Oscillator | Buy |
| Average Directional Index (14) | 16.58 (+DI 19.8 / -DI 19.1) | Trend | Neutral |
| EMA 20 | 31.73 | MA | Buy |
| SMA 20 | 31.47 | MA | Buy |
| EMA 50 | 32.27 | MA | Sell |
| SMA 50 | 32.77 | MA | Sell |
| SMA 200 | 29.86 | MA | Strong Buy |
Stock news · updated daily
HARROGATE, TN / ACCESS Newswire / September 29, 2026 / Commercial Bancgroup, Inc. ("Commercial") (Nasdaq:CBK) announced today details for the release of its financial results for the third quarter of 2026. Commercial plans to issue its earnings release for the third quarter of 2026 on Monday, October 26, 2026, after market close.
HARROGATE, TN / ACCESS Newswire / July 27, 2026 / Commercial Bancgroup, Inc. ("Commercial") (NASDAQ:CBK), the parent company of Commercial Bank, announced today that the board of directors of Commercial declared a quarterly cash dividend of $0.12 per share of Commercial common stock payable on September 30, 2026, to shareholders of record as of the close of business on September 15, 2026. This cash dividend represents a $0.02, or 20.0%, increase over the $0.10 cash dividend paid during the second quarter of 2026.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 27, 2026 | 0.70 | 0.75 | Beat 7.1% | $24.16M |
| Jun 3, 2026 | 0.70 | 0.70 | Miss -0.1% | $30.85M |
| Jan 26, 2026 | 0.72 | 0.72 | Beat 0.6% | $23.48M |
| Oct 27, 2025 | 0.82 | 0.77 | Miss -6.1% | $22.83M |
| Sep 3, 2025 | — | 0.74 | — | $22.30M |
| Mar 31, 2025 | — | 0.66 | — | $33.24M |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 29, 26 | Lee Terry L | director, officer: President and CEO | M-Exempt | 14,167 | — |
| Sep 29, 26 | Lee Terry L | director, officer: President and CEO | F-InKind | 5,242 @ $31.56 | $165.4K |
| Sep 29, 26 | Lee Terry L | director, officer: President and CEO | M-Exempt | 14,167 | — |
| Sep 29, 26 | Lee Terry L | director, officer: President and CEO | A-Award | 4,753 | — |
| Sep 16, 26 | Robertson John Adam | director, officer: Executive Chairperson | P-Purchase | 70 @ $32.69 | $2.29K |
| Aug 26, 26 | Metheny Philip J. | officer: EVP, Chief Financial Officer | P-Purchase | 100 @ $34.11 | $3.41K |
| Aug 25, 26 | Metheny Philip J. | officer: EVP, Chief Financial Officer | P-Purchase | 670 @ $34.79 | $23.31K |
| Aug 20, 26 | Metheny Philip J. | officer: EVP, Chief Financial Officer | P-Purchase | 150 @ $33.77 | $5.07K |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 1, 2026 | 2026-10-01 16:15:24 | View |
| 4 | Sep 28, 2026 | 2026-09-28 19:22:54 | View |
| 4 | Aug 27, 2026 | 2026-08-27 16:11:39 | View |
| 4 | Aug 21, 2026 | 2026-08-21 16:10:30 | View |
| SC 13G/A | Aug 14, 2026 | 2026-08-14 15:23:12 | View |
| 10-Q | Aug 12, 2026 | 2026-08-12 16:38:43 | View |
| 4 | Aug 4, 2026 | 2026-08-04 16:10:25 | View |
| 8-K | Jul 27, 2026 | 2026-07-27 16:10:22 | View |
| SC 13G/A | May 18, 2026 | 2026-05-18 13:22:47 | View |
| 10-Q | May 13, 2026 | 2026-05-13 16:43:00 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | CBK | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 11.0x | 9.1x · sector 20.4x | Discount |
| Forward P/E (FY26E) | 10.8x | EPS est. 2.98 | In line |
| Price / Book | 1.5x | 1.4x | In line |
| Price / Sales | 3.4x | 2.5x | Elevated |
| EV / EBITDA | 8.5x | 7.6x | In line |
| Return on equity | 13.9% | — | Healthy |
| Gross margin | 71.1% | 67.6% | In line |
| Debt / Equity | 0.58 | 0.62 | Moderate |
| Piotroski / Altman Z | 8/9 | Z 0.44 | Distress |
Discounted cash flow model